Esperion Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ESPR and other ETFs, options, and stocks.

About ESPR

Esperion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. 

CEO
Sheldon L. Koenig
CEOSheldon L. Koenig
Employees
294
Employees294
Headquarters
Ann Arbor, Michigan
HeadquartersAnn Arbor, Michigan
Founded
1998
Founded1998
Employees
294
Employees294

ESPR Key Statistics

Market cap
811.73M
Market cap811.73M
Price-Earnings ratio
-30.43
Price-Earnings ratio-30.43
Dividend yield
Dividend yield
Average volume
10.54M
Average volume10.54M
High today
$3.15
High today$3.15
Low today
$3.15
Low today$3.15
Open price
$3.17
Open price$3.17
Volume
22.69K
Volume22.69K
52 Week high
$4.18
52 Week high$4.18
52 Week low
$0.949
52 Week low$0.949

Stock Snapshot

As of today, Esperion Therapeutics(ESPR) shares are valued at $3.15. The company's market cap stands at 811.73M, with a P/E ratio of -30.43.

As of 2026-06-22, Esperion Therapeutics(ESPR) stock has fluctuated between $3.15 and $3.15. The current price stands at $3.15, placing the stock +0.1% above today's low and 0.0% off the high.

The Esperion Therapeutics(ESPR)'s current trading volume is 22.69K, compared to an average daily volume of 10.54M.

During the past year, Esperion Therapeutics(ESPR) stock moved between $0.95 at its lowest and $4.18 at its peak.

During the past year, Esperion Therapeutics(ESPR) stock moved between $0.95 at its lowest and $4.18 at its peak.

ESPR News

TipRanks 3d
Top Esperion Executives Quietly Unload a Wave of Shares

New insider activity at Esperion ( (ESPR) ) has taken place on June 18, 2026. Esperion insiders have been actively trimming their holdings, with three top exec...

CNN 4d
symbol__ Stock Quote Price and Forecast - CNN

...

symbol__ Stock Quote Price and Forecast - CNN
TipRanks 6d
Esperion clears key U.S. antitrust hurdle for merger

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

Analyst ratings

86%

of 7 ratings
Buy
0%
Hold
85.7%
Sell
14.3%

People also own

Based on the portfolios of people who own ESPR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.